Kingsport, TN (January 30, 2013) – Intellectual Property Executives (IPE) announced on Wednesday that it has been given approval by the U.S. Food and Drug Administration to begin Phase-2 clinical... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,